On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor antibody screen on the Ortho Clinical Diagnostics VISION Analyzer. This instrumentation change was necessary as Ortho Clinical Diagnostics will be discontinuing support of the existing ProVue instrumentation in the future.
We will notify you of the transition date of our other four laboratories. To read more about this change, click here: Communications
After a recent reevaluation of the Monolisa anti-HBs EIA package insert, the CTS QA/Scientific team ...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...